Rossari Biotech will expand capacity at its subsidiaries Unitop and Tristar.
Unitop plans to add 18,500 MTPA by Q4 FY26 with an investment of $9.24 million, aimed at supporting new product lines and boosting competitiveness.
Tristar will add 3,600 MTPA to its 15,000 MTPA capacity with $2.4 million to upgrade equipment, enhance efficiency, and cut maintenance costs.